Maturity onset diabetes of the young and pregnancy

Cristina Colom, Rosa Corcoy

Research output: Contribution to journalReview articleResearchpeer-review

51 Citations (Scopus)


Three and a half decades after the clinical description of "Maturity Onset Diabetes of the Young" (MODY), and despite its low prevalence, important knowledge has been gathered concerning its genetic basis, molecular pathways, clinical phenotypes and pharmacogenetic issues. This knowledge has proved to be important not only for the attention of subjects carrying a mutation but also for the insight provided in Type 2 diabetes mellitus. In recent years, a shift from the term "MODY" to "monogenic diabetes" has taken place, the latter term being a better and more comprehensive descriptor. We stick to the "old" term because information on other types of monogenic diabetes and pregnancy is scarce. In this review we perform an overview of the entity, the prevalence rates reported in women with gestational diabetes mellitus and the specific impact of each type on pregnancy outcome. © 2010 Elsevier Ltd. All rights reserved.
Original languageEnglish
Pages (from-to)605-615
JournalBest Practice and Research: Clinical Endocrinology and Metabolism
Issue number4
Publication statusPublished - 1 Jan 2010


  • Birth weight
  • Gestational diabetes mellitus (GDM)
  • MODY
  • Monogenic diabetes


Dive into the research topics of 'Maturity onset diabetes of the young and pregnancy'. Together they form a unique fingerprint.

Cite this